Current understanding of the glial response to disorders of the aging CNS by Francesca eCicchetti, Roger A Barker

Connect to this object online.

Neurodegenerative disorders: The Glia way forward by Roger A Barker, Francesca eCicchetti

Connect to this object online.

The glial response to intracerebrally delivered therapies for neurodegenerative disorders: Is this a critical issue? by Francesca eCicchetti, Roger A Barker

Connect to this object online.

Modelling of a targeted nanotherapeutic 'stroma' to deliver the cytokine LIF, or XAV939, a potent inhibitor of Wnt-β-catenin signalling, for use in human fetal dopaminergic grafts... by Jing-Wei Zhao, Sean C. Dyson, Christina Kriegel, Pam Tyers, Xiaoling He, Tarek M. Fahmy, Su M. Metcalfe, Roger A. Barker

Connect to this object online.

Development and early qualitative evidence of two novel patient-reported outcome instruments to assess daily functioning in people with early-stage Parkinson's by Thomas Morel, Sophie Cleanthous, John Andrejack, Roger A. Barker, Milton Biagioni, Geraldine Blavat, Bastiaan R. Bloem, Babak Boroojerdi, William Brooks, Paul Burns, Stefan Cano, Casey Gallagher, Lesley Gosden, Carroll Siu, Ashley F. Slagle, Natasha Ratcliffe, Karlin Schroeder

Connect to this object online.

Innate immunity and neurodegenerative disorders by Francesca Cicchetti

Other Authors: “…Roger A Barker…”
DOAB: download the publication
DOAB: description of the publication